Production of pigs transgenic for human regulators of complement activation.
Yannoutsos
N
N
Department of Surgery, Cambridge University, Cambridge, UK.
Langford
G A
GA
Cozzi
E
E
Lancaster
R
R
Elsome
K
K
Chen
P
P
White
D J
DJ
D000818:Animals; D030801:Animals, Genetically Modified; D015703:Antigens, CD / Q000096:biosynthesis* / Q000235:genetics; D018958:CD55 Antigens; D018244:Chromosomes, Artificial, Yeast; D003167:Complement Activation; D003169:Complement Inactivator Proteins / Q000096:biosynthesis*; D004247:DNA / Q000032:analysis; D005091:Exons; D005260:Female; D006801:Humans; D007438:Introns; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins / Q000096:biosynthesis* / Q000235:genetics; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009865:Oocytes; D016133:Polymerase Chain Reaction; D021382:Protein Sorting Signals / Q000235:genetics; D012313:RNA / Q000032:analysis; D013552:Swine; D015053:Zygote / Q000502:physiology
D015703:Antigens, CD; C497857:CD46 protein, human; D018958:CD55 Antigens; D003169:Complement Inactivator Proteins; C497859:Mcp protein, mouse; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins; D021382:Protein Sorting Signals; D012313:RNA; D004247:DNA